ZA200502619B - Indole-3-carboxamides as glucokinase (GK) activators - Google Patents
Indole-3-carboxamides as glucokinase (GK) activators Download PDFInfo
- Publication number
- ZA200502619B ZA200502619B ZA200502619A ZA200502619A ZA200502619B ZA 200502619 B ZA200502619 B ZA 200502619B ZA 200502619 A ZA200502619 A ZA 200502619A ZA 200502619 A ZA200502619 A ZA 200502619A ZA 200502619 B ZA200502619 B ZA 200502619B
- Authority
- ZA
- South Africa
- Prior art keywords
- mmol
- solution
- chloro
- reaction
- treated
- Prior art date
Links
- 102000030595 Glucokinase Human genes 0.000 title description 25
- 108010021582 Glucokinase Proteins 0.000 title description 25
- 239000012190 activator Substances 0.000 title description 5
- LSGKMZLPZFPAIN-UHFFFAOYSA-N 1h-indole-3-carboxamide Chemical class C1=CC=C2C(C(=O)N)=CNC2=C1 LSGKMZLPZFPAIN-UHFFFAOYSA-N 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims description 99
- 150000001875 compounds Chemical class 0.000 claims description 81
- 125000001072 heteroaryl group Chemical group 0.000 claims description 36
- -1 nitro, amino, cyano, methyl Chemical group 0.000 claims description 34
- 229910052799 carbon Inorganic materials 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 26
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 17
- 125000005842 heteroatom Chemical group 0.000 claims description 16
- 229910052757 nitrogen Chemical group 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 13
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 13
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 13
- 125000001246 bromo group Chemical group Br* 0.000 claims description 11
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 125000004076 pyridyl group Chemical group 0.000 claims description 10
- 125000000335 thiazolyl group Chemical group 0.000 claims description 10
- 125000003277 amino group Chemical group 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- 239000011593 sulfur Substances 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- 239000001301 oxygen Chemical group 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 5
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 4
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000001590 oxidative effect Effects 0.000 claims description 4
- 238000011321 prophylaxis Methods 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 claims description 3
- 230000000069 prophylactic effect Effects 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 425
- 239000000243 solution Substances 0.000 description 358
- 238000006243 chemical reaction Methods 0.000 description 258
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 163
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 158
- 239000007787 solid Substances 0.000 description 141
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 138
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 130
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 112
- 239000012044 organic layer Substances 0.000 description 112
- 229920006395 saturated elastomer Polymers 0.000 description 100
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 99
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 93
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 93
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 93
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 90
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 79
- 235000019341 magnesium sulphate Nutrition 0.000 description 79
- 239000011780 sodium chloride Substances 0.000 description 65
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 62
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 60
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 58
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 48
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 46
- 238000004587 chromatography analysis Methods 0.000 description 45
- 239000000377 silicon dioxide Substances 0.000 description 45
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 45
- 238000001914 filtration Methods 0.000 description 41
- 239000002244 precipitate Substances 0.000 description 31
- DOCNWGLGOYLWRC-UHFFFAOYSA-N 1-(6-chloro-1h-indol-3-yl)-2,2,2-trifluoroethanone Chemical compound ClC1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 DOCNWGLGOYLWRC-UHFFFAOYSA-N 0.000 description 30
- 235000017557 sodium bicarbonate Nutrition 0.000 description 30
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 30
- 229910000027 potassium carbonate Inorganic materials 0.000 description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 22
- YTYIMDRWPTUAHP-UHFFFAOYSA-N 6-Chloroindole Chemical compound ClC1=CC=C2C=CNC2=C1 YTYIMDRWPTUAHP-UHFFFAOYSA-N 0.000 description 19
- ADTNDYSNPZJBPO-UHFFFAOYSA-N 6-chloro-1-propan-2-ylindole-3-carboxylic acid Chemical compound C1=C(Cl)C=C2N(C(C)C)C=C(C(O)=O)C2=C1 ADTNDYSNPZJBPO-UHFFFAOYSA-N 0.000 description 18
- LWPVWSNNWFQMLW-UHFFFAOYSA-N 1-(6-chloro-1-propan-2-ylindol-3-yl)-2,2,2-trifluoroethanone Chemical compound C1=C(Cl)C=C2N(C(C)C)C=C(C(=O)C(F)(F)F)C2=C1 LWPVWSNNWFQMLW-UHFFFAOYSA-N 0.000 description 16
- 150000001721 carbon Chemical group 0.000 description 16
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 14
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- 125000003118 aryl group Chemical group 0.000 description 12
- 239000010410 layer Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 229910052736 halogen Inorganic materials 0.000 description 8
- 150000002367 halogens Chemical class 0.000 description 8
- 125000006239 protecting group Chemical group 0.000 description 8
- XBTHQAKYJGTLRT-UHFFFAOYSA-N 6-methylsulfanyl-1h-indole Chemical compound CSC1=CC=C2C=CNC2=C1 XBTHQAKYJGTLRT-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- CVPYZHPCSLMXOJ-UHFFFAOYSA-N 6-methoxy-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C=1N(C(C)C)C2=CC(OC)=CC=C2C=1C(=O)NC1=NC=CS1 CVPYZHPCSLMXOJ-UHFFFAOYSA-N 0.000 description 5
- RCZJMRMYXLALSY-UHFFFAOYSA-N 6-methylsulfanyl-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C=1N(C(C)C)C2=CC(SC)=CC=C2C=1C(=O)NC1=NC=CS1 RCZJMRMYXLALSY-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 102000020897 Formins Human genes 0.000 description 5
- 108091022623 Formins Proteins 0.000 description 5
- 239000001828 Gelatine Substances 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- FUPISCQRSFQDIJ-UHFFFAOYSA-N 1-butyl-6-chloro-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(CCCC)C=C1C(=O)NC1=NC=CS1 FUPISCQRSFQDIJ-UHFFFAOYSA-N 0.000 description 4
- ZFOCWZVUOOAMLL-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-methoxy-1-propan-2-ylindol-3-yl)ethanone Chemical compound COC1=CC=C2C(C(=O)C(F)(F)F)=CN(C(C)C)C2=C1 ZFOCWZVUOOAMLL-UHFFFAOYSA-N 0.000 description 4
- HXIAOAVTDAAMOH-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-methoxy-1h-indol-3-yl)ethanone Chemical compound COC1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 HXIAOAVTDAAMOH-UHFFFAOYSA-N 0.000 description 4
- QHIOWKNUCHOWDB-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-methylsulfanyl-1-propan-2-ylindol-3-yl)ethanone Chemical compound CSC1=CC=C2C(C(=O)C(F)(F)F)=CN(C(C)C)C2=C1 QHIOWKNUCHOWDB-UHFFFAOYSA-N 0.000 description 4
- RYJCDMVGBJRUBP-UHFFFAOYSA-N 6-bromo-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Br)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 RYJCDMVGBJRUBP-UHFFFAOYSA-N 0.000 description 4
- SDVNFOCWDDKKDS-UHFFFAOYSA-N 6-chloro-1-(2-methylpropyl)-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(CC(C)C)C=C1C(=O)NC1=NC=CS1 SDVNFOCWDDKKDS-UHFFFAOYSA-N 0.000 description 4
- NTVGXPJLDFYLOG-UHFFFAOYSA-N 6-chloro-1-(3-methylbutyl)-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(CCC(C)C)C=C1C(=O)NC1=NC=CS1 NTVGXPJLDFYLOG-UHFFFAOYSA-N 0.000 description 4
- OFBFUTQBQZVVOA-UHFFFAOYSA-N 6-chloro-1-(cyclobutylmethyl)-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC(Cl)=CC=C2C(C(=O)NC=2SC=CN=2)=CN1CC1CCC1 OFBFUTQBQZVVOA-UHFFFAOYSA-N 0.000 description 4
- LNMRMZXGXHJIKG-UHFFFAOYSA-N 6-chloro-1-(cyclohexylmethyl)-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC(Cl)=CC=C2C(C(=O)NC=2SC=CN=2)=CN1CC1CCCCC1 LNMRMZXGXHJIKG-UHFFFAOYSA-N 0.000 description 4
- LBZZNJGQZZZPPD-UHFFFAOYSA-N 6-chloro-1-(cyclopentylmethyl)-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC(Cl)=CC=C2C(C(=O)NC=2SC=CN=2)=CN1CC1CCCC1 LBZZNJGQZZZPPD-UHFFFAOYSA-N 0.000 description 4
- LXPSBBCFDOCISE-UHFFFAOYSA-N 6-chloro-1-(cyclopropylmethyl)-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC(Cl)=CC=C2C(C(=O)NC=2SC=CN=2)=CN1CC1CC1 LXPSBBCFDOCISE-UHFFFAOYSA-N 0.000 description 4
- ZNJOUQVWCDRXNA-UHFFFAOYSA-N 6-chloro-1-ethyl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(CC)C=C1C(=O)NC1=NC=CS1 ZNJOUQVWCDRXNA-UHFFFAOYSA-N 0.000 description 4
- SOJLBRADUNVKNI-UHFFFAOYSA-N 6-chloro-1-propan-2-yl-n-(1,3,4-thiadiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=NN=CS1 SOJLBRADUNVKNI-UHFFFAOYSA-N 0.000 description 4
- QNRCBIJYCMLRHF-UHFFFAOYSA-N 6-chloro-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 QNRCBIJYCMLRHF-UHFFFAOYSA-N 0.000 description 4
- LMSMGWZIWLSHIH-UHFFFAOYSA-N 6-chloro-n-(4-methyl-1,3-thiazol-2-yl)-1-propan-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=NC(C)=CS1 LMSMGWZIWLSHIH-UHFFFAOYSA-N 0.000 description 4
- ZUPHCNCFMORKNL-UHFFFAOYSA-N 6-chloro-n-(5-chloro-1,3-thiazol-2-yl)-1-propan-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=NC=C(Cl)S1 ZUPHCNCFMORKNL-UHFFFAOYSA-N 0.000 description 4
- IMNXRVLOSOSBHE-UHFFFAOYSA-N 6-chloro-n-(5-methylpyridin-2-yl)-1-propan-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=CC=C(C)C=N1 IMNXRVLOSOSBHE-UHFFFAOYSA-N 0.000 description 4
- WCQIQZYNMUIBII-UHFFFAOYSA-N 6-fluoro-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(F)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 WCQIQZYNMUIBII-UHFFFAOYSA-N 0.000 description 4
- HABRVPZQAMXYED-UHFFFAOYSA-N 6-hydroxy-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(O)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 HABRVPZQAMXYED-UHFFFAOYSA-N 0.000 description 4
- OWWBQEHXEUHJLJ-UHFFFAOYSA-N 6-methoxy-1-propan-2-ylindole-3-carboxylic acid Chemical compound COC1=CC=C2C(C(O)=O)=CN(C(C)C)C2=C1 OWWBQEHXEUHJLJ-UHFFFAOYSA-N 0.000 description 4
- YIQARNFOXUXVME-UHFFFAOYSA-N 6-methyl-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(C)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 YIQARNFOXUXVME-UHFFFAOYSA-N 0.000 description 4
- OHGOUAJZUAJWCJ-UHFFFAOYSA-N 6-methylsulfonyl-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(S(C)(=O)=O)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 OHGOUAJZUAJWCJ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- LHODXAMSQRKFAC-UHFFFAOYSA-N ethyl 2-[2-[(6-chloro-1-propan-2-ylindole-3-carbonyl)amino]-1,3-thiazol-4-yl]acetate Chemical compound CCOC(=O)CC1=CSC(NC(=O)C=2C3=CC=C(Cl)C=C3N(C(C)C)C=2)=N1 LHODXAMSQRKFAC-UHFFFAOYSA-N 0.000 description 4
- 230000003914 insulin secretion Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- BLZRNDNHMFRVTQ-UHFFFAOYSA-N 1-propan-2-yl-n-(1,3-thiazol-2-yl)-6-(trifluoromethyl)indole-3-carboxamide Chemical compound C12=CC=C(C(F)(F)F)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 BLZRNDNHMFRVTQ-UHFFFAOYSA-N 0.000 description 3
- DZCQHDQCFVJUOQ-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-methylsulfanyl-1h-indol-3-yl)ethanone Chemical compound CSC1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 DZCQHDQCFVJUOQ-UHFFFAOYSA-N 0.000 description 3
- MAWGHOPSCKCTPA-UHFFFAOYSA-N 6-bromo-1h-indole Chemical compound BrC1=CC=C2C=CNC2=C1 MAWGHOPSCKCTPA-UHFFFAOYSA-N 0.000 description 3
- AELBJURYEBTTMC-UHFFFAOYSA-N 6-chloro-1-pentylindole-3-carboxylic acid Chemical compound C1=C(Cl)C=C2N(CCCCC)C=C(C(O)=O)C2=C1 AELBJURYEBTTMC-UHFFFAOYSA-N 0.000 description 3
- CGLXTVMIXXCBNX-UHFFFAOYSA-N 6-chloro-1-propan-2-yl-n-[5-(trifluoromethyl)pyridin-2-yl]indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=CC=C(C(F)(F)F)C=N1 CGLXTVMIXXCBNX-UHFFFAOYSA-N 0.000 description 3
- CUGBXVMMHDKBKG-UHFFFAOYSA-N 6-chloro-1-propan-2-yl-n-pyridin-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=CC=CC=N1 CUGBXVMMHDKBKG-UHFFFAOYSA-N 0.000 description 3
- GLKNKHJEYLKDFO-UHFFFAOYSA-N 6-chloro-1-propyl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(CCC)C=C1C(=O)NC1=NC=CS1 GLKNKHJEYLKDFO-UHFFFAOYSA-N 0.000 description 3
- RGFCKDMZXZKUNF-UHFFFAOYSA-N 6-chloro-1-propylindole-3-carboxylic acid Chemical compound C1=C(Cl)C=C2N(CCC)C=C(C(O)=O)C2=C1 RGFCKDMZXZKUNF-UHFFFAOYSA-N 0.000 description 3
- YBVZCAUPWCCTIN-UHFFFAOYSA-N 6-methylsulfanyl-1-propan-2-ylindole-3-carboxylic acid Chemical compound CSC1=CC=C2C(C(O)=O)=CN(C(C)C)C2=C1 YBVZCAUPWCCTIN-UHFFFAOYSA-N 0.000 description 3
- HUFLACPTOCPPNA-UHFFFAOYSA-N 6-nitro-1-propan-2-yl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C([N+]([O-])=O)C=C2N(C(C)C)C=C1C(=O)NC1=NC=CS1 HUFLACPTOCPPNA-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 102000005548 Hexokinase Human genes 0.000 description 3
- 108700040460 Hexokinases Proteins 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 235000019502 Orange oil Nutrition 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 230000004153 glucose metabolism Effects 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002475 indoles Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- VGCMVAMTZDVGPS-UHFFFAOYSA-N n-(5-bromo-1,3-thiazol-2-yl)-6-chloro-1-propan-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=NC=C(Br)S1 VGCMVAMTZDVGPS-UHFFFAOYSA-N 0.000 description 3
- 239000010502 orange oil Substances 0.000 description 3
- OXCNAMATIDVWKG-UHFFFAOYSA-N 1-(6-bromo-1-propan-2-ylindol-3-yl)-2,2,2-trifluoroethanone Chemical compound C1=C(Br)C=C2N(C(C)C)C=C(C(=O)C(F)(F)F)C2=C1 OXCNAMATIDVWKG-UHFFFAOYSA-N 0.000 description 2
- NUILEHCMTCIUPS-UHFFFAOYSA-N 1-(6-bromo-1h-indol-3-yl)-2,2,2-trifluoroethanone Chemical compound BrC1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 NUILEHCMTCIUPS-UHFFFAOYSA-N 0.000 description 2
- DPLHNWDFILHYAY-UHFFFAOYSA-N 1-[6-chloro-1-(2-methylpropyl)indol-3-yl]-2,2,2-trifluoroethanone Chemical compound C1=C(Cl)C=C2N(CC(C)C)C=C(C(=O)C(F)(F)F)C2=C1 DPLHNWDFILHYAY-UHFFFAOYSA-N 0.000 description 2
- CCNBTAZKTZVEQU-UHFFFAOYSA-N 1-butyl-6-chloroindole-3-carboxylic acid Chemical compound C1=C(Cl)C=C2N(CCCC)C=C(C(O)=O)C2=C1 CCNBTAZKTZVEQU-UHFFFAOYSA-N 0.000 description 2
- PKCRTZDYWNMJBM-UHFFFAOYSA-N 1-propan-2-yl-6-(trifluoromethyl)indole-3-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2N(C(C)C)C=C(C(O)=O)C2=C1 PKCRTZDYWNMJBM-UHFFFAOYSA-N 0.000 description 2
- ZJOAWANBGDSTFS-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-fluoro-1-propan-2-ylindol-3-yl)ethanone Chemical compound C1=C(F)C=C2N(C(C)C)C=C(C(=O)C(F)(F)F)C2=C1 ZJOAWANBGDSTFS-UHFFFAOYSA-N 0.000 description 2
- DFMVRDWKCSSAGP-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-fluoro-1h-indol-3-yl)ethanone Chemical compound FC1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 DFMVRDWKCSSAGP-UHFFFAOYSA-N 0.000 description 2
- CYXLUBVIOAWIOE-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-methyl-1-propan-2-ylindol-3-yl)ethanone Chemical compound C1=C(C)C=C2N(C(C)C)C=C(C(=O)C(F)(F)F)C2=C1 CYXLUBVIOAWIOE-UHFFFAOYSA-N 0.000 description 2
- FGKOAZGNYHYTKU-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-methyl-1h-indol-3-yl)ethanone Chemical compound CC1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 FGKOAZGNYHYTKU-UHFFFAOYSA-N 0.000 description 2
- YABVWMCHRGUANR-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-nitro-1-propan-2-ylindol-3-yl)ethanone Chemical compound C1=C([N+]([O-])=O)C=C2N(C(C)C)C=C(C(=O)C(F)(F)F)C2=C1 YABVWMCHRGUANR-UHFFFAOYSA-N 0.000 description 2
- CNGASWCHKORNNV-UHFFFAOYSA-N 2,2,2-trifluoro-1-(6-nitro-1h-indol-3-yl)ethanone Chemical compound [O-][N+](=O)C1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 CNGASWCHKORNNV-UHFFFAOYSA-N 0.000 description 2
- HLSDJVYGSAZPIH-UHFFFAOYSA-N 2,2,2-trifluoro-1-[1-propan-2-yl-6-(trifluoromethyl)indol-3-yl]ethanone Chemical compound C1=C(C(F)(F)F)C=C2N(C(C)C)C=C(C(=O)C(F)(F)F)C2=C1 HLSDJVYGSAZPIH-UHFFFAOYSA-N 0.000 description 2
- PIFKQXLSUQZRAM-UHFFFAOYSA-N 2,2,2-trifluoro-1-[6-(trifluoromethyl)-1h-indol-3-yl]ethanone Chemical compound FC(F)(F)C1=CC=C2C(C(=O)C(F)(F)F)=CNC2=C1 PIFKQXLSUQZRAM-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- SZVUEGIULUFQQG-UHFFFAOYSA-N 6-bromo-1-propan-2-ylindole-3-carboxylic acid Chemical compound C1=C(Br)C=C2N(C(C)C)C=C(C(O)=O)C2=C1 SZVUEGIULUFQQG-UHFFFAOYSA-N 0.000 description 2
- ICXRVVRXQVZYLW-UHFFFAOYSA-N 6-chloro-1-(2-methylpropyl)indole-3-carboxylic acid Chemical compound C1=C(Cl)C=C2N(CC(C)C)C=C(C(O)=O)C2=C1 ICXRVVRXQVZYLW-UHFFFAOYSA-N 0.000 description 2
- LKGCOYTYJUDGNU-UHFFFAOYSA-N 6-chloro-1-(cyclobutylmethyl)indole-3-carboxylic acid Chemical compound C12=CC(Cl)=CC=C2C(C(=O)O)=CN1CC1CCC1 LKGCOYTYJUDGNU-UHFFFAOYSA-N 0.000 description 2
- YAKUOJOZBFTTLT-UHFFFAOYSA-N 6-chloro-1-(cyclohexylmethyl)indole-3-carboxylic acid Chemical compound C12=CC(Cl)=CC=C2C(C(=O)O)=CN1CC1CCCCC1 YAKUOJOZBFTTLT-UHFFFAOYSA-N 0.000 description 2
- QZPTZISJOAPIPJ-UHFFFAOYSA-N 6-chloro-1-(cyclopentylmethyl)indole-3-carboxylic acid Chemical compound C12=CC(Cl)=CC=C2C(C(=O)O)=CN1CC1CCCC1 QZPTZISJOAPIPJ-UHFFFAOYSA-N 0.000 description 2
- SWJIUTLINVNONA-UHFFFAOYSA-N 6-chloro-1-(cyclopropylmethyl)indole-3-carboxylic acid Chemical compound C12=CC(Cl)=CC=C2C(C(=O)O)=CN1CC1CC1 SWJIUTLINVNONA-UHFFFAOYSA-N 0.000 description 2
- ICZPGZWFGGWUAD-UHFFFAOYSA-N 6-chloro-1-ethylindole-3-carboxylic acid Chemical compound C1=C(Cl)C=C2N(CC)C=C(C(O)=O)C2=C1 ICZPGZWFGGWUAD-UHFFFAOYSA-N 0.000 description 2
- AJMJGXWITJECDW-UHFFFAOYSA-N 6-chloro-1-pentyl-n-(1,3-thiazol-2-yl)indole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(CCCCC)C=C1C(=O)NC1=NC=CS1 AJMJGXWITJECDW-UHFFFAOYSA-N 0.000 description 2
- VXZMKUAWLBUJHJ-UHFFFAOYSA-N 6-chloro-n-(5-chloropyridin-2-yl)-1-propan-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=CC=C(Cl)C=N1 VXZMKUAWLBUJHJ-UHFFFAOYSA-N 0.000 description 2
- FXCGKGLCGXHELL-UHFFFAOYSA-N 6-chloro-n-(5-methyl-1,3-thiazol-2-yl)-1-propan-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=NC=C(C)S1 FXCGKGLCGXHELL-UHFFFAOYSA-N 0.000 description 2
- VFXWNYYYVZDZMH-UHFFFAOYSA-N 6-fluoro-1-propan-2-ylindole-3-carboxylic acid Chemical compound C1=C(F)C=C2N(C(C)C)C=C(C(O)=O)C2=C1 VFXWNYYYVZDZMH-UHFFFAOYSA-N 0.000 description 2
- YYFFEPUCAKVRJX-UHFFFAOYSA-N 6-fluoro-1h-indole Chemical compound FC1=CC=C2C=CNC2=C1 YYFFEPUCAKVRJX-UHFFFAOYSA-N 0.000 description 2
- QJRWYBIKLXNYLF-UHFFFAOYSA-N 6-methoxy-1h-indole Chemical compound COC1=CC=C2C=CNC2=C1 QJRWYBIKLXNYLF-UHFFFAOYSA-N 0.000 description 2
- UIFLPMDEUXWWNN-UHFFFAOYSA-N 6-methyl-1-propan-2-ylindole-3-carboxylic acid Chemical compound C1=C(C)C=C2N(C(C)C)C=C(C(O)=O)C2=C1 UIFLPMDEUXWWNN-UHFFFAOYSA-N 0.000 description 2
- FAFXMARQFYNUNJ-UHFFFAOYSA-N 6-nitro-1-propan-2-ylindole-3-carboxylic acid Chemical compound C1=C([N+]([O-])=O)C=C2N(C(C)C)C=C(C(O)=O)C2=C1 FAFXMARQFYNUNJ-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101150109586 Gk gene Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000035180 MODY Diseases 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 238000007126 N-alkylation reaction Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 125000003435 aroyl group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 125000001033 ether group Chemical group 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000014101 glucose homeostasis Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000002346 iodo group Chemical group I* 0.000 description 2
- DUMSKQUKLVSSII-UHFFFAOYSA-N iodomethylcyclopentane Chemical compound ICC1CCCC1 DUMSKQUKLVSSII-UHFFFAOYSA-N 0.000 description 2
- 201000006950 maturity-onset diabetes of the young Diseases 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- LNXVDESQMJEDIF-UHFFFAOYSA-N n-(1,3-thiazol-2-yl)-1h-indole-3-carboxamide Chemical compound C=1NC2=CC=CC=C2C=1C(=O)NC1=NC=CS1 LNXVDESQMJEDIF-UHFFFAOYSA-N 0.000 description 2
- JTAUXTITNNBYMP-UHFFFAOYSA-N n-(5-bromopyridin-2-yl)-6-chloro-1-propan-2-ylindole-3-carboxamide Chemical compound C12=CC=C(Cl)C=C2N(C(C)C)C=C1C(=O)NC1=CC=C(Br)C=N1 JTAUXTITNNBYMP-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 2
- 229910000105 potassium hydride Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- QUKGLNCXGVWCJX-UHFFFAOYSA-N 1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=CS1 QUKGLNCXGVWCJX-UHFFFAOYSA-N 0.000 description 1
- VWWHRCWQTSIYMV-UHFFFAOYSA-N 1-(1-butyl-6-chloroindol-3-yl)-2,2,2-trifluoroethanone Chemical compound C1=C(Cl)C=C2N(CCCC)C=C(C(=O)C(F)(F)F)C2=C1 VWWHRCWQTSIYMV-UHFFFAOYSA-N 0.000 description 1
- CVEJKJCNKXRGCI-UHFFFAOYSA-N 1-(6-chloro-1-propylindol-3-yl)-2,2,2-trifluoroethanone Chemical compound C1=C(Cl)C=C2N(CCC)C=C(C(=O)C(F)(F)F)C2=C1 CVEJKJCNKXRGCI-UHFFFAOYSA-N 0.000 description 1
- VJMBQVZQSARJCZ-UHFFFAOYSA-N 1-[6-chloro-1-(3-methylbutyl)indol-3-yl]-2,2,2-trifluoroethanone Chemical compound C1=C(Cl)C=C2N(CCC(C)C)C=C(C(=O)C(F)(F)F)C2=C1 VJMBQVZQSARJCZ-UHFFFAOYSA-N 0.000 description 1
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 1
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 1
- YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical compound CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 1
- LHWIMUYVNQXLOV-UHFFFAOYSA-N 1H-indole-2,6-dicarbonitrile Chemical compound C1=C(C#N)C=C2NC(C#N)=CC2=C1 LHWIMUYVNQXLOV-UHFFFAOYSA-N 0.000 description 1
- NZYQZEUIWASHRZ-UHFFFAOYSA-N 1h-indole-2,6-diamine Chemical compound C1=C(N)C=C2NC(N)=CC2=C1 NZYQZEUIWASHRZ-UHFFFAOYSA-N 0.000 description 1
- OTKXXJYYVZSYHT-UHFFFAOYSA-N 1h-indole-2,6-diol Chemical compound C1=C(O)C=C2NC(O)=CC2=C1 OTKXXJYYVZSYHT-UHFFFAOYSA-N 0.000 description 1
- CJKQIQAGEVBXBL-UHFFFAOYSA-N 2,6-bis(trifluoromethyl)-1H-indole Chemical compound C1=C(C(F)(F)F)C=C2NC(C(F)(F)F)=CC2=C1 CJKQIQAGEVBXBL-UHFFFAOYSA-N 0.000 description 1
- WENWBPUCDBMSSI-UHFFFAOYSA-N 2,6-dibromo-1h-indole Chemical compound C1=C(Br)C=C2NC(Br)=CC2=C1 WENWBPUCDBMSSI-UHFFFAOYSA-N 0.000 description 1
- QUFBKANNFIKCBB-UHFFFAOYSA-N 2,6-dichloro-1h-indole Chemical compound C1=C(Cl)C=C2NC(Cl)=CC2=C1 QUFBKANNFIKCBB-UHFFFAOYSA-N 0.000 description 1
- FBSPUHVZEUKPLS-UHFFFAOYSA-N 2,6-dimethoxy-1H-indole Chemical compound C1=C(OC)C=C2NC(OC)=CC2=C1 FBSPUHVZEUKPLS-UHFFFAOYSA-N 0.000 description 1
- IVEOPBYBMLADDC-UHFFFAOYSA-N 2,6-dimethyl-1h-indole Chemical compound C1=C(C)C=C2NC(C)=CC2=C1 IVEOPBYBMLADDC-UHFFFAOYSA-N 0.000 description 1
- OSEWWBOKSRUGHQ-UHFFFAOYSA-N 2,6-dinitro-1H-indole Chemical compound C1=C([N+]([O-])=O)C=C2NC([N+](=O)[O-])=CC2=C1 OSEWWBOKSRUGHQ-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 1
- ZLOCOQNMVGDMBT-UHFFFAOYSA-N 2-[(5,6-dihydroxy-4-methoxy-2h-pyran-2-yl)oxy]-4-methoxy-2h-pyran-5,6-diol Chemical class O1C(O)=C(O)C(OC)=CC1OC1C=C(OC)C(O)=C(O)O1 ZLOCOQNMVGDMBT-UHFFFAOYSA-N 0.000 description 1
- XMXLBDNVSIHRRA-UHFFFAOYSA-N 2-amino-4,5-dimethyl-thiazole Natural products CC=1N=C(N)SC=1C XMXLBDNVSIHRRA-UHFFFAOYSA-N 0.000 description 1
- JCXQALZKJUWFQI-UHFFFAOYSA-N 2-chloro-1-propan-2-yl-n-pyridin-2-ylindole-3-carboxamide Chemical compound C12=CC=CC=C2N(C(C)C)C(Cl)=C1C(=O)NC1=CC=CC=N1 JCXQALZKJUWFQI-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XYTUTNQRQLAZLK-UHFFFAOYSA-N 4,5-dimethyl-1,3-thiazol-2-amine;hydrochloride Chemical compound Cl.CC=1N=C(N)SC=1C XYTUTNQRQLAZLK-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- OUQMXTJYCAJLGO-UHFFFAOYSA-N 4-methyl-1,3-thiazol-2-amine Chemical compound CC1=CSC(N)=N1 OUQMXTJYCAJLGO-UHFFFAOYSA-N 0.000 description 1
- ARHCLXWELPFVFQ-UHFFFAOYSA-N 5-bromo-1,3-thiazol-2-amine Chemical compound NC1=NC=C(Br)S1 ARHCLXWELPFVFQ-UHFFFAOYSA-N 0.000 description 1
- GUABFMPMKJGSBQ-UHFFFAOYSA-N 5-methyl-1,3-thiazol-2-amine Chemical compound CC1=CN=C(N)S1 GUABFMPMKJGSBQ-UHFFFAOYSA-N 0.000 description 1
- CMBSSVKZOPZBKW-UHFFFAOYSA-N 5-methylpyridin-2-amine Chemical compound CC1=CC=C(N)N=C1 CMBSSVKZOPZBKW-UHFFFAOYSA-N 0.000 description 1
- DODJNBPQUZSJKO-UHFFFAOYSA-N 6-(trifluoromethoxy)-1h-indole Chemical compound FC(F)(F)OC1=CC=C2C=CNC2=C1 DODJNBPQUZSJKO-UHFFFAOYSA-N 0.000 description 1
- BPYBYPREOVLFED-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole Chemical compound FC(F)(F)C1=CC=C2C=CNC2=C1 BPYBYPREOVLFED-UHFFFAOYSA-N 0.000 description 1
- QSZXAJWECRTKDJ-UHFFFAOYSA-N 6-chloro-1-(3-methylbutyl)indole-3-carboxylic acid Chemical compound C1=C(Cl)C=C2N(CCC(C)C)C=C(C(O)=O)C2=C1 QSZXAJWECRTKDJ-UHFFFAOYSA-N 0.000 description 1
- UYFYWUXBZHYQRM-UHFFFAOYSA-N 6-iodo-1h-indole Chemical compound IC1=CC=C2C=CNC2=C1 UYFYWUXBZHYQRM-UHFFFAOYSA-N 0.000 description 1
- ONYNOPPOVKYGRS-UHFFFAOYSA-N 6-methyl-1h-indole Chemical compound CC1=CC=C2C=CNC2=C1 ONYNOPPOVKYGRS-UHFFFAOYSA-N 0.000 description 1
- PSWCIARYGITEOY-UHFFFAOYSA-N 6-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2C=CNC2=C1 PSWCIARYGITEOY-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101150043532 CISH gene Proteins 0.000 description 1
- 101100532679 Caenorhabditis elegans scc-1 gene Proteins 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 240000000244 Crotalaria pallida Species 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 238000013313 FeNO test Methods 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- PGLJGCIDAOFWSK-UHFFFAOYSA-N NC1=NC=C[S+]1Cl Chemical compound NC1=NC=C[S+]1Cl PGLJGCIDAOFWSK-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- CHIHQLCVLOXUJW-UHFFFAOYSA-N benzoic anhydride Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C1=CC=CC=C1 CHIHQLCVLOXUJW-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- FLHFTXCMKFVKRP-UHFFFAOYSA-N bromomethylcyclobutane Chemical compound BrCC1CCC1 FLHFTXCMKFVKRP-UHFFFAOYSA-N 0.000 description 1
- UUWSLBWDFJMSFP-UHFFFAOYSA-N bromomethylcyclohexane Chemical compound BrCC1CCCCC1 UUWSLBWDFJMSFP-UHFFFAOYSA-N 0.000 description 1
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical class ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- ISQVBYGGNVVVHB-UHFFFAOYSA-N cyclopentylmethanol Chemical compound OCC1CCCC1 ISQVBYGGNVVVHB-UHFFFAOYSA-N 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- SHQNGLYXRFCPGZ-UHFFFAOYSA-N ethyl 2-(2-amino-1,3-thiazol-4-yl)acetate Chemical compound CCOC(=O)CC1=CSC(N)=N1 SHQNGLYXRFCPGZ-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000006343 heptafluoro propyl group Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 238000011905 homologation Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- KMAKOBLIOCQGJP-UHFFFAOYSA-N indole-3carboxylic acid Natural products C1=CC=C2C(C(=O)O)=CNC2=C1 KMAKOBLIOCQGJP-UHFFFAOYSA-N 0.000 description 1
- 239000008011 inorganic excipient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000004457 myocytus nodalis Anatomy 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000008012 organic excipient Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 238000005897 peptide coupling reaction Methods 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000029964 regulation of glucose metabolic process Effects 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-N tert-butylcarbamic acid Chemical compound CC(C)(C)NC(O)=O XBXCNNQPRYLIDE-UHFFFAOYSA-N 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- UDOZVPVDQKQJAP-UHFFFAOYSA-N trifluoroamine oxide Chemical compound [O-][N+](F)(F)F UDOZVPVDQKQJAP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41573702P | 2002-10-03 | 2002-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200502619B true ZA200502619B (en) | 2006-03-29 |
Family
ID=32069904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200502619A ZA200502619B (en) | 2002-10-03 | 2006-01-19 | Indole-3-carboxamides as glucokinase (GK) activators |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6881844B2 (ja) |
| EP (1) | EP1549638B1 (ja) |
| JP (1) | JP4390704B2 (ja) |
| KR (1) | KR100646486B1 (ja) |
| CN (1) | CN100348596C (ja) |
| AR (1) | AR041467A1 (ja) |
| AT (1) | ATE374768T1 (ja) |
| AU (1) | AU2003270285B2 (ja) |
| BR (1) | BR0315047A (ja) |
| CA (1) | CA2499329C (ja) |
| DE (1) | DE60316709T2 (ja) |
| DK (1) | DK1549638T3 (ja) |
| ES (1) | ES2293005T3 (ja) |
| HK (1) | HK1083098A1 (ja) |
| HR (1) | HRP20050287A2 (ja) |
| MX (1) | MXPA05003391A (ja) |
| MY (1) | MY136764A (ja) |
| NO (1) | NO20051103L (ja) |
| NZ (1) | NZ538466A (ja) |
| PA (1) | PA8584001A1 (ja) |
| PE (1) | PE20050090A1 (ja) |
| PL (1) | PL375149A1 (ja) |
| PT (1) | PT1549638E (ja) |
| RU (1) | RU2309956C2 (ja) |
| SI (1) | SI1549638T1 (ja) |
| TW (1) | TW200413364A (ja) |
| UY (1) | UY28005A1 (ja) |
| WO (1) | WO2004031179A1 (ja) |
| ZA (1) | ZA200502619B (ja) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| WO2004050645A1 (en) * | 2002-10-03 | 2004-06-17 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0226930D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| CA2560689C (en) | 2004-04-02 | 2011-03-01 | Novartis Ag | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes |
| CA2561157A1 (en) | 2004-04-02 | 2005-10-13 | Novartis Ag | Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| WO2006112549A1 (ja) | 2005-04-20 | 2006-10-26 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物 |
| US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| KR20080048504A (ko) | 2005-09-29 | 2008-06-02 | 사노피-아벤티스 | 페닐- 및 피리디닐-1,2,4-옥사디아졸론 유도체, 이의제조방법 및 약제로서의 이의 용도 |
| CA2623958C (en) * | 2005-09-30 | 2013-05-28 | Banyu Pharmaceutical Co., Ltd. | 2-heteroaryl-substituted indole derivative |
| GT200600428A (es) * | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
| GT200600429A (es) * | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
| JP2009013065A (ja) * | 2005-10-14 | 2009-01-22 | Astellas Pharma Inc | 縮合へテロ環化合物 |
| EP1948614A2 (en) * | 2005-11-18 | 2008-07-30 | Takeda San Diego, Inc. | Glucokinase activators |
| US7351706B2 (en) * | 2006-01-05 | 2008-04-01 | Hoffmann-La Roche Inc. | Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
| EP1849785A1 (en) * | 2006-04-28 | 2007-10-31 | Neuropharma, S.A. | N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| WO2007143434A2 (en) * | 2006-05-31 | 2007-12-13 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents |
| EP2508524A3 (en) * | 2006-10-19 | 2012-10-24 | Takeda Pharmaceutical Company Limited | Indole compound |
| WO2008074694A1 (en) * | 2006-12-20 | 2008-06-26 | F. Hoffmann-La Roche Ag | Crystallization of glucokinase activators |
| JP5419706B2 (ja) | 2006-12-20 | 2014-02-19 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼアクチベーター |
| WO2008116107A2 (en) | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Piperazine derivatives as glucokinase activators |
| NZ582056A (en) * | 2007-08-10 | 2012-08-31 | Lundbeck & Co As H | Bicyclic heteroaryl compounds for treating conditions related to p2x7 receptor activation |
| KR20110018366A (ko) * | 2008-05-16 | 2011-02-23 | 다케다 샌디에고, 인코포레이티드 | 글루코키나아제 활성제 |
| US8835644B2 (en) | 2009-03-20 | 2014-09-16 | University Of Virginia Patent Foundation | Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |
| JP2011006366A (ja) | 2009-06-26 | 2011-01-13 | Sanwa Kagaku Kenkyusho Co Ltd | 新規チオフェンカルボキサミド誘導体及びその医薬用途 |
| WO2012040170A2 (en) | 2010-09-20 | 2012-03-29 | University Of Virginia Patent Foundation | Compositions and methods for treating tuberculosis |
| CN103044310B (zh) * | 2013-01-18 | 2015-02-04 | 贵阳医学院 | 二氢吲哚-3-乙酸衍生物、其制备方法以及在药物中的应用 |
| WO2023067628A1 (en) * | 2021-10-20 | 2023-04-27 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | A method for the preparation of indole-3-carboxylic acid derivatives |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| JP5278983B2 (ja) | 1999-11-17 | 2013-09-04 | 塩野義製薬株式会社 | アミド化合物の新規用途 |
| PT1341774E (pt) | 2000-12-06 | 2006-05-31 | Hoffmann La Roche | Activadores heteroaromaticos, fundidos de glicocinase |
| US6433188B1 (en) | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
| US6482951B2 (en) | 2000-12-13 | 2002-11-19 | Hoffmann-La Roche Inc. | Isoindolin-1-one glucokinase activators |
| IL156064A0 (en) | 2000-12-28 | 2003-12-23 | Daiichi Seiyaku Co | Vla-4 inhibitors |
| UA77303C2 (en) * | 2002-06-14 | 2006-11-15 | Pfizer | Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use |
-
2003
- 2003-09-26 PT PT03750648T patent/PT1549638E/pt unknown
- 2003-09-26 RU RU2005113719/04A patent/RU2309956C2/ru not_active IP Right Cessation
- 2003-09-26 SI SI200331008T patent/SI1549638T1/sl unknown
- 2003-09-26 DE DE60316709T patent/DE60316709T2/de not_active Expired - Lifetime
- 2003-09-26 AU AU2003270285A patent/AU2003270285B2/en not_active Ceased
- 2003-09-26 DK DK03750648T patent/DK1549638T3/da active
- 2003-09-26 WO PCT/EP2003/010776 patent/WO2004031179A1/en active IP Right Grant
- 2003-09-26 JP JP2004540731A patent/JP4390704B2/ja not_active Expired - Fee Related
- 2003-09-26 KR KR1020057005669A patent/KR100646486B1/ko not_active IP Right Cessation
- 2003-09-26 BR BR0315047-0A patent/BR0315047A/pt not_active IP Right Cessation
- 2003-09-26 CA CA002499329A patent/CA2499329C/en not_active Expired - Fee Related
- 2003-09-26 AT AT03750648T patent/ATE374768T1/de not_active IP Right Cessation
- 2003-09-26 ES ES03750648T patent/ES2293005T3/es not_active Expired - Lifetime
- 2003-09-26 NZ NZ538466A patent/NZ538466A/en unknown
- 2003-09-26 PL PL03375149A patent/PL375149A1/xx not_active Application Discontinuation
- 2003-09-26 MX MXPA05003391A patent/MXPA05003391A/es active IP Right Grant
- 2003-09-26 CN CNB038236796A patent/CN100348596C/zh not_active Expired - Fee Related
- 2003-09-26 EP EP03750648A patent/EP1549638B1/en not_active Expired - Lifetime
- 2003-09-30 US US10/674,481 patent/US6881844B2/en not_active Expired - Fee Related
- 2003-09-30 PE PE2003000988A patent/PE20050090A1/es not_active Application Discontinuation
- 2003-09-30 PA PA20038584001A patent/PA8584001A1/es unknown
- 2003-09-30 TW TW092127030A patent/TW200413364A/zh unknown
- 2003-10-01 UY UY28005A patent/UY28005A1/es not_active Application Discontinuation
- 2003-10-01 AR ARP030103589A patent/AR041467A1/es unknown
- 2003-10-01 MY MYPI20033742A patent/MY136764A/en unknown
-
2005
- 2005-03-01 NO NO20051103A patent/NO20051103L/no not_active Application Discontinuation
- 2005-03-24 HR HR20050287A patent/HRP20050287A2/xx not_active Application Discontinuation
-
2006
- 2006-01-19 ZA ZA200502619A patent/ZA200502619B/en unknown
- 2006-04-10 HK HK06104334A patent/HK1083098A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200502619B (en) | Indole-3-carboxamides as glucokinase (GK) activators | |
| CA2407416C (en) | Alkynyl phenyl heteroaromatic glucokinase activators | |
| KR100520651B1 (ko) | 이소인돌린-1-온 글루코키나제 활성화제 | |
| CA2407763C (en) | Para-amine substituted phenylamide glucokinase activators | |
| EP1282611B1 (en) | Substituted phenylacetamides and their use as glucokinase activators | |
| AU2001270494A1 (en) | Alkynyl phenyl heteroaromatic glucokinase activators | |
| KR20120047960A (ko) | 글루코키나아제(ｇｋ) 활성화제로서 치환된 벤즈아미드 유도체 |